Projects overview

Sort by

Toggle all information

ELASTISLET | Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche

01-06-2015

-

31-05-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.3. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
H2020-EU.2.1.3.1. Cross-cutting and enabling materials technologies
H2020-NMP-2014-two-stage
NMP-10-2014 Biomaterials for the treatment of diabetes mellitus

DRIVE | Diabetes Reversing Implants with enhanced Viability and long-term Efficacy

01-06-2015

-

31-05-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.3. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
H2020-EU.2.1.3.1. Cross-cutting and enabling materials technologies
H2020-NMP-2014-two-stage
NMP-10-2014 Biomaterials for the treatment of diabetes mellitus

BIOCAPAN | BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy

01-06-2015

-

30-09-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.3. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
H2020-EU.2.1.3.1. Cross-cutting and enabling materials technologies
H2020-NMP-2014-two-stage
NMP-10-2014 Biomaterials for the treatment of diabetes mellitus
Powered by Chris Decubber BV